These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 24396830)

  • 1. Off-label use of ondansetron in pregnancy in Western Australia.
    Colvin L; Gill AW; Slack-Smith L; Stanley FJ; Bower C
    Biomed Res Int; 2013; 2013():909860. PubMed ID: 24396830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ondansetron for Treatment of Nausea and Vomiting of Pregnancy and the Risk of Specific Birth Defects.
    Parker SE; Van Bennekom C; Anderka M; Mitchell AA;
    Obstet Gynecol; 2018 Aug; 132(2):385-394. PubMed ID: 29995744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ondansetron in pregnancy and risk of adverse fetal outcomes in the United States.
    Fejzo MS; MacGibbon KW; Mullin PM
    Reprod Toxicol; 2016 Jul; 62():87-91. PubMed ID: 27151373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Pregnancy Outcomes of Patients Treated With Ondansetron vs Alternative Antiemetic Medications in a Multinational, Population-Based Cohort.
    Dormuth CR; Winquist B; Fisher A; Wu F; Reynier P; Suissa S; Dahl M; Ma Z; Lu X; Zhang J; Raymond CB; Filion KB; Platt RW; Moriello C; Paterson JM;
    JAMA Netw Open; 2021 Apr; 4(4):e215329. PubMed ID: 33890993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ondansetron looks safe in pregnancy, so far.
    BMJ; 2013 Mar; 346():f1387. PubMed ID: 23468289
    [No Abstract]   [Full Text] [Related]  

  • 6. Association of Maternal First-Trimester Ondansetron Use With Cardiac Malformations and Oral Clefts in Offspring.
    Huybrechts KF; Hernández-Díaz S; Straub L; Gray KJ; Zhu Y; Patorno E; Desai RJ; Mogun H; Bateman BT
    JAMA; 2018 Dec; 320(23):2429-2437. PubMed ID: 30561479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major Congenital Malformation Risk After First Trimester Gestational Exposure to Oral or Intravenous Ondansetron.
    Andrade C
    J Clin Psychiatry; 2020 Jun; 81(3):. PubMed ID: 32526103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interventions for treating hyperemesis gravidarum.
    Boelig RC; Barton SJ; Saccone G; Kelly AJ; Edwards SJ; Berghella V
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD010607. PubMed ID: 27168518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ondansetron Use During Pregnancy: Birth Defects and Obstetric Outcomes.
    Masarwe S; Shvartsur R; Hadar E; Betesh-Abay B; Peleg N; Azab AN
    Clin Nurs Res; 2023 May; 32(4):705-711. PubMed ID: 36912091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gaining Insight Into Ondansetron Safety in Early Pregnancy.
    Lavecchia M; Chari R; Ross S
    J Obstet Gynaecol Can; 2019 Apr; 41(4):419-420. PubMed ID: 30685231
    [No Abstract]   [Full Text] [Related]  

  • 11. Motherisk update. Is ondansetron safe for use during pregnancy?
    Koren G
    Can Fam Physician; 2012 Oct; 58(10):1092-3. PubMed ID: 23064917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A survey of prescribing for the management of nausea and vomiting in pregnancy in Australasia.
    Raymond SH
    Aust N Z J Obstet Gynaecol; 2013 Aug; 53(4):358-62. PubMed ID: 23346891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ondansetron use during pregnancy: a case series.
    Ferreira E; Gillet M; Lelièvre J; Bussières JF
    J Popul Ther Clin Pharmacol; 2012; 19(1):e1-e10. PubMed ID: 22267256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ondansetron Use in Pregnancy and Birth Defects: A Systematic Review.
    Carstairs SD
    Obstet Gynecol; 2016 May; 127(5):878-883. PubMed ID: 27054939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ondansetron in Pregnancy and the Risk of Congenital Malformations: A Systematic Review.
    Lavecchia M; Chari R; Campbell S; Ross S
    J Obstet Gynaecol Can; 2018 Jul; 40(7):910-918. PubMed ID: 29754832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hyperemesis gravidarum with the 5-HT3 antagonist ondansetron (Zofran).
    Tincello DG; Johnstone MJ
    Postgrad Med J; 1996 Nov; 72(853):688-9. PubMed ID: 8944215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ondansetron compared with metoclopramide for hyperemesis gravidarum: a randomized controlled trial.
    Abas MN; Tan PC; Azmi N; Omar SZ
    Obstet Gynecol; 2014 Jun; 123(6):1272-1279. PubMed ID: 24807340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiemetic use among pregnant women in the United States: the escalating use of ondansetron.
    Taylor LG; Bird ST; Sahin L; Tassinari MS; Greene P; Reichman ME; Andrade SE; Haffenreffer K; Toh S
    Pharmacoepidemiol Drug Saf; 2017 May; 26(5):592-596. PubMed ID: 28220993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First trimester ondansetron exposure and risk of structural birth defects.
    Zambelli-Weiner A; Via C; Yuen M; Weiner DJ; Kirby RS
    Reprod Toxicol; 2019 Jan; 83():14-20. PubMed ID: 30385129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ondansetron Use in Pregnancy.
    Siminerio LL; Bodnar LM; Venkataramanan R; Caritis SN
    Obstet Gynecol; 2016 May; 127(5):873-877. PubMed ID: 27054931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.